D. E. Shaw & Co., Inc. - TRANSMEDICS GROUP INC ownership

TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 224 filers reported holding TRANSMEDICS GROUP INC in Q3 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of TRANSMEDICS GROUP INC
ValueSharesWeighting
Q2 2024$33,116,970
+3239.5%
219,871
+1650.0%
0.03%
+3000.0%
Q4 2023$991,677
-96.3%
12,564
-96.1%
0.00%
-96.4%
Q2 2023$27,039,461
-19.2%
321,975
-27.2%
0.03%
-22.2%
Q1 2023$33,470,691
+44.7%
441,974
+18.0%
0.04%
+38.5%
Q4 2022$23,124,385
+614.6%
374,666
+383.3%
0.03%
+550.0%
Q3 2022$3,236,00077,5260.00%
Other shareholders
TRANSMEDICS GROUP INC shareholders Q3 2023
NameSharesValueWeighting ↓
Lagoda Investment Management, L.P. 65,035$9,795,5725.64%
Sandhill Capital Partners LLC 434,974$65,515,7165.02%
APIS CAPITAL ADVISORS, LLC 40,000$6,024,8004.45%
NEXT CENTURY GROWTH INVESTORS LLC 336,397$50,668,1164.21%
First Light Asset Management, LLC 300,600$45,276,3723.97%
Bullseye Asset Management LLC 49,000$7,3803.61%
Eagle Health Investments LP 132,861$20,011,5243.51%
First Turn Management, LLC 139,780$21,053,6643.42%
Eventide Asset Management 1,145,430$172,524,6672.95%
Montanaro Asset Management Ltd 104,250$15,702,1352.93%
View complete list of TRANSMEDICS GROUP INC shareholders